Capricor Therapeutics, Inc. (CAPR) Financials
CAPR Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 58.7 million | 36.1 million |
2023-09-30 | 37.2 million | 38.9 million |
2023-06-30 | 46.0 million | 43.3 million |
2023-03-31 | 53.9 million | 47.7 million |
CAPR Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -12.3 million | 1.9 million |
2023-09-30 | -9.4 million | 1.7 million |
2023-06-30 | -9.7 million | 1.6 million |
2023-03-31 | 3.8 million | 2.2 million |
CAPR Net Income
No data available :(
CAPR Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 39.5 million | - | 2.2 million |
2023-09-30 | 28.5 million | - | 2.4 million |
2023-06-30 | 37.8 million | 3.4 million | 2.2 million |
2023-03-31 | 45.2 million | 3.4 million | 2.4 million |
CAPR Shares Outstanding
CAPR Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 729222 | 9.8 million | 3.0 million | 85056 |
2023-09-30 | 631753 | 10.0 million | 3.0 million | - |
2023-06-30 | 233443 | 8.8 million | 2.8 million | - |
2023-03-31 | 453115 | 7.7 million | 3.5 million | - |
CAPR Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 12.1 million | 307608 |
2023-09-30 | 6.2 million | 276471 |
2023-06-30 | 3.9 million | 248250 |
2023-03-31 | 3.0 million | 7.7 million |
CAPR
Price: $5.47
52 week price:
Earnings Per Share: -0.83 USD
P/E Ratio: -3.42
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 60100
Ebitda: -2.6 millionMarket Capitalization: 184.6 million